Press ReleaseJuly 18, 2007Researchers have found a gene variant that can more than double the risk of age-related macular degeneration (AMD).The researchers based their findings on studies of patients with AMD (603 from England and 244 from Scotland) who were compared with 701 unaffected people. They found that a variant in the complement C3 gene […]
by Dan Roberts February 2006 Dr. Jayakrishna Ambati (University of Kentucky HealthCare physician and Associate Professor and Vice Chair of the Department of Ophthalmology and Visual Sciences), has announced that his lab has identified fragments of two known components of drusen that may be the cause of dry age-related macular degeneration (AMD) progressing to the […]
by Dan Roberts with additional material by Wendy Strouse Watt, O.D. Originally Published October 26, 2005 Acuity Medical has successfully completed a proof of concept, double-masked trial of its TheraMac™ device for the treatment of dry age-related macular degeneration (AMD). The therapy developed from early studies of microcurrent stimulation, with improvements in the science and […]
by Dan Roberts March 2005 A research team at the University of California, San Diego (UCSD) School of Medicine and the University of Utah have developed a mouse model of Age-Related Macular Degeneration (AMD) and Stargardt’s disease. As reported in the online edition of the Proceedings of the National Academy of Sciences (March 4, 2005), […]
by Judy Prevost March 4, 2000 (Updated November 2004) Age Related Macular Degeneration (ARMD) is the leading cause of severe vision loss in people over the age of 65. This can be caused by the growth of abnormal blood vessels and neovascularization under the macula, or in the center of the macula, leading to loss […]